Giacomo Boccuzzi
A5047202802- Coronary Interventions and Diagnostics
- Acute Myocardial Infarction Research
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiac Imaging and Diagnostics
- Atrial Fibrillation Management and Outcomes
- Venous Thromboembolism Diagnosis and Management
- Cardiac Valve Diseases and Treatments
- Cardiac Structural Anomalies and Repair
- Cardiac Arrhythmias and Treatments
- Mechanical Circulatory Support Devices
- Cerebrovascular and Carotid Artery Diseases
- Peripheral Artery Disease Management
- Cardiovascular Issues in Pregnancy
- Aortic aneurysm repair treatments
- Vascular Procedures and Complications
- Cardiac tumors and thrombi
- Cardiac Arrest and Resuscitation
- Cardiovascular Function and Risk Factors
- Infective Endocarditis Diagnosis and Management
- Cardiac, Anesthesia and Surgical Outcomes
- Lipoproteins and Cardiovascular Health
- Ultrasound in Clinical Applications
- Kawasaki Disease and Coronary Complications
- Heart Failure Treatment and Management
- COVID-19 and healthcare impacts
Ospedale San Giovanni Bosco
2016-2025
Azienda Socio Sanitaria Territoriale Lariana
2024
Surgical Specialties (Canada)
2024
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
2024
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda
2024
Vita-Salute San Raffaele University
2024
Istituti di Ricovero e Cura a Carattere Scientifico
2024
Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele
2024
University of Brescia
2024
University of Pavia
2024
fully explained by Covid-19 cases alone. 5This observation and data from our study raise the question of wheth-
Conflicting evidence exists on the efficacy and safety of bivalirudin administered as part percutaneous coronary intervention (PCI) in patients with an acute syndrome.We randomly assigned 7213 syndrome for whom PCI was anticipated to receive either or unfractionated heparin. Patients group were subsequently not a post-PCI infusion. Primary outcomes comparison between heparin occurrence major adverse cardiovascular events (a composite death, myocardial infarction, stroke) net clinical...
There are limited data regarding the impact of final kissing balloon (FKI) in patients treated with percutaneous coronary intervention using ultrathin stents left main or bifurcations.All undergoing bifurcations enrolled RAIN registry (Very Thin Stents for Patients With MAIN BiF Real Life: The RAIN, a Multicenter Study) evaluating were included. Major adverse cardiac event (a composite all-cause death, myocardial infarction, target lesion revascularization, and stent thrombosis) was primary...
The aim of this multicentre study was to investigate the in-hospital and midterm outcomes rotational atherectomy (RA) followed by metallic stent implantation.Between 2002 2013, 1,176 de novo lesions with calcified coronary treated RA implantation at nine institutions were assessed. Patients ST-segment elevation myocardial infarction (STEMI) within 30 days, cardiogenic shock before procedure, thrombus, in-stent restenosis excluded from current analysis. In-hospital major adverse cardiac...
Objectives We aimed to investigate procedural feasibility and outcomes associated with planned rotational atherectomy (RA) for severely calcified coronary lesions. Background: Limited data are available addressing the benefits of RA compared provisional RA. Methods Between 2002 2013, all patients lesions treated by were enrolled. Of these, (358 patients) those (309 patients). Results In‐hospital major adverse cardiovascular events (MACE) tended be better in group (unadjusted OR: 0.76; 95%...
Delayed healing and endothelial dysfunction may occur with drug-eluting stents (DES), promoting accelerated infiltration of lipids in the neointima development neoatherosclerosis (NA). Pathology data suggest durable polymer (DP) DES to play a major role this process. Whether biodegradable (BP) address these issues is uncertain. We compared vivo vessel NA current generation BP- or DP-DES using serial optical coherence tomography (OCT) assessments.Ninety patients multivessel coronary artery...
Aims:The safety and efficacy of rotational atherectomy (RA) in patients presenting with non-ST-elevation myocardial infarction (NSTE-ACS) remain to be defined.The aim our study was assess the RA NSTE-ACS reference both short-and long-term follow-up. Methods results:This an observational retrospective registry which enrolled all consecutive undergoing RA, comparing stable angina (SA) NSTE-ACS.In addition, ACS were matched those not RA.The primary endpoint angiographic success.Procedural...
The aim of the present study was to establish safety and efficacy profile prasugrel ticagrelor in real-life acute coronary syndrome (ACS) patients with renal dysfunction.All consecutive from RENAMI (REgistry New Antiplatelets Myocardial Infarction) BLEEMACS (Bleeding complications a Multicenter registry discharged diagnosis Acute Coronary Syndrome) registries were stratified according estimated glomerular filtration rate (eGFR) lower or greater than 60 mL/min/1.73 m2. Death myocardial...
Objective Left atrial appendage (LAA) thrombus has heretofore been considered a contraindication to percutaneous LAA closure (LAAC). Data regarding its management are very limited. The aim of this study was analyse the medical and invasive treatment patients referred for LAAC in presence thrombus. Methods This multicentre observational registry included 126 consecutive with on preprocedural imaging. Treatment strategies intensification antithrombotic therapy (IAT) or direct LAAC. primary...
ABSTRACT Background Performing a left atrial appendage occlusion (LAAO) or catheter ablation with left‐sided intracardiac thrombus is considered very‐high risk for periinterventional stroke. Cerebral embolic protection (CEP) devices are designed to prevent cardioembolic stroke and have been widely studied in TAVR procedures. However, their role LAAO of ventricular tachycardia (VT) pulmonary vein isolation (PVI) cardiac present remains unknown. Purpose study utility safety CEP during patients...
Background Rotational atherectomy (RA) is relatively contraindicated in patients with lesions ≥25 mm of length. Aim this study was to evaluate RA safety and efficacy subset new technology devices. Methods Results From April 2002 August 2013, the ROTATE registry included all consecutive undergoing 8 centres. They were divided into shorter lesion group (SLG, < 25 mm) longer (LLG, ≥ mm). The angiographic success (AS) primary end point. Procedural complications (PC), a composite point...